Zobrazeno 1 - 10
of 73
pro vyhledávání: '"K E Zatolochina"'
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 2, Pp 17-21 (2022)
The article presents the results of assessing the benefits and risks balance of BCG vaccine in Russia carried out by the «Principle of three» method
Externí odkaz:
https://doaj.org/article/8fb803521fab453db80eb251bc477505
Publikováno v:
Антибиотики и Химиотерапия, Vol 63, Iss 5-6, Pp 46-51 (2020)
The main objective of this study was to analyze the adverse drug reactions (ADRs) associated with the use of levofloxacin. We analyzed ADR reports submitted to the Russian Spontaneous Report Database from 2009 to 2017. A significant difference in the
Externí odkaz:
https://doaj.org/article/92e94670a4c84f9ab6dacce16047a934
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 12, Iss 1, Pp 100-104 (2020)
Acute pain, especially musculoskeletal and postoperative pain, is widespread pathology associated with quality of life deterioration, temporary disability, a tendency to relapse, and, in some cases, chronicity, so the timely and adequate treatment of
Externí odkaz:
https://doaj.org/article/8b487327f99549b0adcc438d655bb151
Publikováno v:
Терапевтический архив, Vol 91, Iss 12, Pp 122-127 (2019)
The role of immune mechanisms in the pathogenesis of almost all human diseases shown in recent decades, increase in antibiotic resistance and secondary immunodeficiency, aging of the population and widespread use of immunosuppressive drugs and proced
Externí odkaz:
https://doaj.org/article/bbce0f0cec61404ebe2cc2ed48fd5826
Autor:
A. S. Kazakov, E. V. Shubnikova, M. A. Darmostukova, I. I. Snegireva, G. V. Kutekhova, K. E. Zatolochina, N. Yu. Velts, D. A. Kaperko, Yu. V. Olefir
Publikováno v:
Безопасность и риск фармакотерапии, Vol 7, Iss 3, Pp 120-126 (2019)
In the 1960s, following the Thalidomide Disaster, the World Health Organization (WHO) initiated the development of an international drug safety monitoring programme. The objectives of this WHO programme are to improve the quality and safety of pharma
Externí odkaz:
https://doaj.org/article/b6d8dc91215348808819a2a332b5cf2d
Publikováno v:
Безопасность и риск фармакотерапии, Vol 7, Iss 2, Pp 84-92 (2019)
Multiple sclerosis is one of the most common neurological diseases of working age population. The last 20 years widely use drugs that change the course of multiple sclerosis. The article is devoted to the problems of the safety of treatment of multip
Externí odkaz:
https://doaj.org/article/297ae0aa00e04ec1bdd7cc0ab511a71e
Autor:
A. S. Kazakov, M. A. Darmostukova, T. M. Bukatina, I. I. Snegireva, V. K. Lepakhin, K. E. Zatolochina
Publikováno v:
Безопасность и риск фармакотерапии, Vol 6, Iss 3, Pp 118-122 (2018)
Myopathy is a life-threatening disease that can be caused, among other things, by the intake of various medications. Despite the fact that many drug-induced myopathies are well known, however, many health professionals are not alert to myopathies cau
Externí odkaz:
https://doaj.org/article/d458f340a1194c3aaa0cc814427cd287
Autor:
S. K. Zyryanov, K. E. Zatolochina
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 51-57 (2018)
This article reviews perspective of the targeted radionuclide therapy (TRT) as one of the rapidly growing fields of nuclear medicine. The characteristics, features of action, advantages and disadvantages of the most used α- and β-emitters (223Ra, 2
Externí odkaz:
https://doaj.org/article/2ea073cacdb840c0a70967e8cab56a9d
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 10, Iss 1S, Pp 75-80 (2018)
A policy on generic substitutions, which is aimed at reducing the cost-effectiveness of pharmacotherapy, was proposed by the WHO at the end of the 20th century; however, but the debate about their economic benefits has continued until now. There have
Externí odkaz:
https://doaj.org/article/f3b3558fabb54bc69fdf9e35a1ccf7a5
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 0, Iss 1, Pp 51-55 (2018)
The article presents an analysis of 522 cases of complications after BCG vaccination, i.e. post-vaccinal osteomyelitis, based on pharmacovigilance data obtained between 2001 and 2012. A detailed study of ill children revealed no clinical manifestatio
Externí odkaz:
https://doaj.org/article/b9bef6043ac646849457ed104f7e8580